170 related articles for article (PubMed ID: 34291061)
1. Association of HIV-1 Infection and Antiretroviral Therapy With Type 2 Diabetes in the Hispanic Population of the Rio Grande Valley, Texas, USA.
Lopez-Alvarenga JC; Martinez DA; Diaz-Badillo A; Morales LD; Arya R; Jenkinson CP; Curran JE; Lehman DM; Blangero J; Duggirala R; Mummidi S; Martinez RD
Front Med (Lausanne); 2021; 8():676979. PubMed ID: 34291061
[TBL] [Abstract][Full Text] [Related]
2. Commentary on Metabolic Health Disparities Affecting the Rio Grande Valley Mexican American Population: Seeking Answers Using Animal Models.
Lopez-Alvarenga JC; Rasa C; Banu J; Mito S; Chavez AO; Reyna SM
Ethn Dis; 2023 Jan; 33(1):55-60. PubMed ID: 38846261
[TBL] [Abstract][Full Text] [Related]
3. The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley.
De La Garza R; Rodrigo H; Fernandez F; Roy U
Curr HIV Res; 2019; 17(6):377-387. PubMed ID: 31663481
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
Pollard RB; Rockstroh JK; Pantaleo G; Asmuth DM; Peters B; Lazzarin A; Garcia F; Ellefsen K; Podzamczer D; van Lunzen J; Arastéh K; Schürmann D; Clotet B; Hardy WD; Mitsuyasu R; Moyle G; Plettenberg A; Fisher M; Fätkenheuer G; Fischl M; Taiwo B; Baksaas I; Jolliffe D; Persson S; Jelmert O; Hovden AO; Sommerfelt MA; Wendel-Hansen V; Sørensen B
Lancet Infect Dis; 2014 Apr; 14(4):291-300. PubMed ID: 24525316
[TBL] [Abstract][Full Text] [Related]
5. Kaposi sarcoma incidence in females is nearly four-fold higher in the Lower Rio Grande Valley compared to the Texas average.
Innis-Whitehouse W; Wang X; Restrepo N; Salas C; Moreno K; Restrepo A; Keniry M
Cancer Treat Res Commun; 2018; 16():45-52. PubMed ID: 31299002
[TBL] [Abstract][Full Text] [Related]
6. Injecting drug use is associated with HIV risk perception among Mexican Americans in the Rio Grande Valley of South Texas, USA.
Essien EJ; Ogungbade GO; Ward D; Fernandez-Esquer ME; Smith CR; Holmes L
Public Health; 2008 Apr; 122(4):397-403. PubMed ID: 17961614
[TBL] [Abstract][Full Text] [Related]
7. Adolescent obesity in a low-income Mexican American district in South Texas.
Lacar ES; Soto X; Riley WJ
Arch Pediatr Adolesc Med; 2000 Aug; 154(8):837-40. PubMed ID: 10922283
[TBL] [Abstract][Full Text] [Related]
8. The role of community health workers in combating type 2 diabetes in the rio grande valley.
Ryabov I; Richardson C
J Prim Care Community Health; 2011 Jan; 2(1):21-5. PubMed ID: 23804658
[TBL] [Abstract][Full Text] [Related]
9. Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.
Rockstroh JK; Asmuth D; Pantaleo G; Clotet B; Podzamczer D; van Lunzen J; Arastéh K; Mitsuyasu R; Peters B; Silvia N; Jolliffe D; Ökvist M; Krogsgaard K; Sommerfelt MA
PLoS One; 2019; 14(1):e0210965. PubMed ID: 30699178
[TBL] [Abstract][Full Text] [Related]
10. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.
Bourgi K; Jenkins CA; Rebeiro PF; Palella F; Moore RD; Altoff KN; Gill J; Rabkin CS; Gange SJ; Horberg MA; Margolick J; Li J; Wong C; Willig A; Lima VD; Crane H; Thorne J; Silverberg M; Kirk G; Mathews WC; Sterling TR; Lake J; Koethe JR;
J Int AIDS Soc; 2020 Apr; 23(4):e25484. PubMed ID: 32294337
[TBL] [Abstract][Full Text] [Related]
11. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Zerbe A; le Roux DM; Kroon M; Myer L
Lancet Child Adolesc Health; 2020 Mar; 4(3):220-231. PubMed ID: 31932246
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.
Althoff KN; Stewart C; Humes E; Gerace L; Boyd C; Gebo K; Justice AC; Hyle EP; Coburn SB; Lang R; Silverberg MJ; Horberg MA; Lima VD; Gill MJ; Karris M; Rebeiro PF; Thorne J; Rich AJ; Crane H; Kitahata M; Rubtsova A; Wong C; Leng S; Marconi VC; D'Souza G; Kim HN; Napravnik S; McGinnis K; Kirk GD; Sterling TR; Moore RD; Kasaie P
PLoS Med; 2024 Jan; 21(1):e1004325. PubMed ID: 38215160
[TBL] [Abstract][Full Text] [Related]
14. Anti-Immigrant Rhetoric, Deteriorating Health Access, and COVID-19 in the Rio Grande Valley, Texas.
Blackburn CC; Sierra LA
Health Secur; 2021 Jun; 19(S1):S50-S56. PubMed ID: 33926220
[TBL] [Abstract][Full Text] [Related]
15. Changes in racial/ethnic disparities in the prevalence of Type 2 diabetes by obesity level among US adults.
Zhang Q; Wang Y; Huang ES
Ethn Health; 2009 Oct; 14(5):439-57. PubMed ID: 19360513
[TBL] [Abstract][Full Text] [Related]
16. Bridging Bone Health: Osteoporosis Disparities in the Rio Grande Valley.
Bialaszewski RP; Gaddis JM; Martin B; Dentino P; Ronnau J
Cureus; 2023 Dec; 15(12):e51115. PubMed ID: 38274901
[TBL] [Abstract][Full Text] [Related]
17. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort.
Brar I; Shuter J; Thomas A; Daniels E; Absalon J;
J Acquir Immune Defic Syndr; 2007 May; 45(1):66-71. PubMed ID: 17245229
[TBL] [Abstract][Full Text] [Related]
18. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522
[TBL] [Abstract][Full Text] [Related]
19. Postvaccination C-Reactive Protein and C5/gp41
Huang Y; Zhang L; Jolliffe D; Sanchez B; Stjernholm G; Jelmert Ø; Ökvist M; Sommerfelt MA
AIDS Res Hum Retroviruses; 2018 Mar; 34(3):307-313. PubMed ID: 29297230
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
